The receptor tyrosine kinase c-Kit plays an integral role in maintaining β-cell mass and function. 
Introduction
The receptor tyrosine kinase c-Kit plays an important role in β-cell function and maturation (1-
5). Mice with a heterozygous global mutation of c-Kit (c-Kit
Wv/+ ) demonstrated a severe loss of β-cell mass and impaired insulin release (6) (7) (8) , whereas restoration of c-Kit expression specifically in β-cells of these mice resulted in increased β-cell mass and improved glucose tolerance (9) . Increasing evidence suggests that c-Kit and its ligand, stem cell factor (SCF), are implicated in the regulation of angiogenesis. SCF treatment of different c-Kit-expressing neoplastic cell lines revealed a significant stimulatory effect on VEGF secretion, which was inhibited by the tyrosine kinase inhibitor imatinib (10) (11) (12) . Additionally, bone marrow stem/progenitor cells expressing c-Kit can establish a proangiogenic milieu by releasing VEGF (13, 14) , while a mutation resulting in loss of function in c-Kit in bone marrow stem/progenitor cells prevented angiogenesis by interfering with myocardial repair tissue formation (14) .
Vascular innervation of islets is required for proper endocrine pancreatic organogenesis (15) , mediated by VEGF-A production from β-cells (16) (17) (18) . Prior studies, using a β-cell-specific VEGF-Adeficient mouse model, demonstrated that abnormally developed vasculature impairs islet architecture and glucose metabolism (15, 16, 18) . In contrast, more recent reports have demonstrated that a β-cell specific de novo induction of VEGF-A-stimulated endothelial cell (EC) activation is associated with a progressive loss in β-cell function and mass (19, 20) . Thus, further studies are required to examine the underlying mechanisms that regulate VEGF-A production in β-cells.
The correlation between c-Kit and angiogenesis in different cell types has been established in previous research, yet whether c-Kit serves a primary role in regulating islet vascular remodelling by mediating VEGF-A production needs to be clarified. It is widely accepted that the vascular niche provides oxygen and exchanges nutrients and metabolites to support β-cell survival (18) , but it can also expose islets to inflammatory mediators under abnormal metabolic conditions (20) (21) (22) . Here, we aimed to investigate the role of c-Kit-mediated VEGF-A and islet vasculature, and its impact on islet survival mice were excluded from this study. All animal work was performed under protocols approved by the Animal Use Subcommittee at the University of Western Ontario in accordance with the guidelines of the Canadian Council of Animal Care.
Metabolic studies on experimental mouse models
Metabolic studies on c-KitβTg:Wv mice with their aged-matched experimental littermates at 8 weeks of age were previously reported (9) . Body weight, blood glucose levels, and IPGTT and IPITT were performed on WT and c-KitβTg mice at 4, 10, 16, and 20-22 weeks post-HFD, and 28 weeks of age (9) . For IPGTT and IPITT, an intraperitoneal injection of glucose (D-(+)-glucose; Sigma, St. Louis, MO) at a dosage of 2 mg/g of body weight or human insulin (Humalin, Eli Lilly, Toronto, ON) at 1 U/kg of body weight was administrated, respectively. Blood glucose levels were measured before and after injection, and the area under curve (AUC) was used to quantify responsiveness.
INS-1 cell and ex vivo islet cultures
INS-1 832/13 cells were cultured in RPMI-1640 medium containing 10% FBS (Invitrogen, Burlington, ON) (8) . At 80% confluency, INS-1 cells were starved in serum-free RPMI-1640 medium containing 1% BSA overnight prior to the experiment. For SCF stimulation studies, cells were treated for 24 hours with human recombinant SCF at 10-100 ng/mL (dissolved in acetic acid, ID labs, London, ON) or cultured with SCF at 50 ng/mL for 1, 6 or 24 hours; controls were treated with the same amount of SCF vehicle. For the c-Kit siRNA studies, INS-1 cells were transiently transfected for 72 hours with either c-Kit(r) siRNA (sc-36533) or control siRNA (sc-37007) followed by treatment of 50 ng/mL of SCF or SCF vehicle for 24 hours (8) . For signaling inhibitory studies, INS-1 cells were pretreated with either Lys294002 (a PI3K inhibitor) at 1-100 µmol/L (dissolved in DMSO; Promega, Madison, WI) or Rapamycin (a mTOR inhibitor) at 1-100 nmol/L (dissolved in DMSO, LC Laboratories, Woburn, MA) for 30 minutes, and then cultured with SCF (50 ng/mL) or SCF vehicle. Cells were processed for RNA or protein extraction, or fixed for immunocytochemistry studies, and culture media were collected for VEGF-A secretion analysis.
Primary islets were isolated from WT and c-KitβTg mice at 10 weeks of age, and cultured in RPMI 1640 media plus 1% BSA with or without SCF (50 ng/mL) for 24 hours. Islets were harvested for protein extraction, and culture media were collected for VEGF-A secretion analysis.
ELISA assay for VEGF-A and insulin
INS-1 cell and ex vivo islet culture media were harvested and analyzed with a Murine VEGF mini-ELISA kit (Peprotech, Rocky Hill, NJ). For the in vivo glucose stimulated insulin secretion (GSIS) assay, mouse plasma was collected following 4 hours of fasting (0 minutes), and at 5 and 35 minutes after glucose loading. Insulin secretion was measured using an ultrasensitive (mouse) insulin ELISA kit (ALPCO, Salem, NH) (9).
Immunofluorescence and morphometric analyses
Mouse pancreata were fixed in 4% PFA and embedded in paraffin. Sections were prepared and stained with primary antibodies at appropriate dilutions provided in Supplementary Table 1 . Images were captured using Image Pro Plus software (MediaCybernetics, Rockville, MD). Quantitative evaluations of islet density, average islet and β-cell size, and total β-cell mass were performed as previously described (8, 9) . Endocrine compartment vasculature (islet capillary density, capillary area per islet, average islet capillary size and diameter) and exocrine compartment vasculature (exocrine capillary density and area) were measured (18, 21) . Islet EC and β-cell proliferation, transcription factor expression, and macrophage infiltration were determined by double immunofluorescence or immunohistochemical staining (8, 9) . Cell apoptosis was quantified by TUNEL + labeling on insulin + cells. A minimum of 10-12 random islets per pancreatic section per experimental group were analyzed, with at least four pancreata per age per experimental group (8, 9) . 
Protein extraction and western blot analysis

RNA extraction and real-time RT-PCR analysis
Total RNA was extracted from INS-1 cells and mouse islets using the RNAqueous-4PCR kit (Invitrogen) (6) . Sequences of PCR primers are provided in Supplementary Table 2 . Real-time PCR analyses were performed using the iQ SYBR Green Supermix kit (Bio-Rad Laboratories). Relative levels of gene expression were calculated and normalized to the internal standard, 18S rRNA. Controls were performed by omitting reverse transcriptase, cDNA, or DNA polymerase (8, 9) .
Statistical analysis
Data are expressed as mean ± SEM. Statistical significance was determined by paired or unpaired student's t-test if comparing only two groups, or one-way ANOVA followed by Fisher's least significant difference (LSD) post-hoc tests if analyzing more than two groups. Differences were considered to be statistically significant when P<0.05.
Results
c-Kit signaling regulates VEGF-A production via the Akt/mTOR pathway in β-cells
INS-1 832/13 cells were previously found to have high expression of c-Kit (5, 8) , and under SCF stimulation displayed enhanced VEGF-A secretion in a dose and time-dependent fashion ( Fig. 1A and B) associated with increased phosphorylation of c-Kit (Fig. 1E ). Cells treated with 50 ng/mL SCF for 24 hours exhibited a 3-fold increases in HIF-1α and VEGF-A mRNA expression (Fig. 1C) , and ~30% increase in VEGF-A protein levels when compared to controls (Fig. 1D) . siRNA-mediated c-Kit knockdown significantly decreased SCF-stimulated c-Kit phosphorylation ( Fig. 2A) and resulted in a down-regulation of VEGF-A content and secretion (Fig. 2B) . Ex vivo islets cultures showed that VEGF-A secretion from WT islets was not significantly induced after SCF stimulation, yet a higher level of VEGF-A secretion was observed in SCF-treated c-KitβTg islets (Supplementary Fig. 1A ).
VEGF-A protein levels were also significantly elevated in c-KitβTg-SCF islets compared to WT groups ( Supplementary Fig. 1B ), suggesting that c-Kit signaling mediates VEGF-A production in β-cells. increase in average capillary size ( Fig. 3D ) and islet capillary diameter (Fig. 3E) , in both c-KitβTg and c-KitβTg:Wv mouse islets. Interestingly, islet vasculature morphologies were comparable among WT, c-KitβTg, and c-KitβTg:Wv mice at 8 weeks of age ( Fig. 3A-E ). These results demonstrate that c-Kit function is required for maintaining normal vasculature in mouse islets.
c-Kit modulates islet vasculature via the Akt/mTOR pathway and VEGF-A production in vivo
In parallel to our INS-1 study, we examined whether the Akt/mTOR signaling pathway was involved in maintaining islet vasculature in vivo. In c-Kit Wv/+ islets, we found significant decreases in the phosphorylation of Akt, P70S6K, and NFκBp65 ( Fig. 3F) , with a ~40% reduction in VEGF-A and a ~50% decline in Pdx-1 protein levels ( Fig. 2 ), supporting the fact that islet vasculature is important for islet transcription factor expression and function.
c-Kit overexpression in β-cells increases islet vasculature, islet number, and β-cell proliferation
Islet vasculature in aged mice was examined to determine whether c-Kit-mediated vascularization is age-dependent. At 28 weeks of age, c-KitβTg islets showed increased PECAM-1 + staining (Fig. 4A ), islet capillary density (Fig. 4B) , and vessel area-to-islet area ratios (Fig. 4C) , with 1.6-fold increased islet EC proliferation (1.7±0.2%) compared to WT groups (1.1±0.3%). However, no changes in average capillary size or diameter in the islets ( Fig. 4D and E) , and no vascular alterations in exocrine pancreas were observed (Supplementary Fig. 3A and B). Increased islet capillary density was corroborated by total increase of PECAM-1 protein levels and a ~40% increase in islet VEGF-A content in aged c-KitβTg islets (Fig. 4F ). While increased vasculature was associated with islet expansion through increased islet density and size ( Fig. 4G and H) , no changes in average β-cell size were observed, but increased β-cell mass and proliferative capacity were found (Fig. 4I-K) . The expression of islet transcriptional factors Pdx-1 and Nkx6.1 ( Supplementary Fig. 3C ) were relative enhanced in aged c-KitβTg mice compared to WT. Additionally, aged c-KitβTg mice displayed improved overnight fasting blood glucose (Fig. 4L) and better glucose tolerance, as revealed by significant decreases in AUC of IPGTT (Fig. 4M) , no changes in insulin tolerance were found ( Supplementary Fig. 3D ). Although there were no changes in islet capillary density between the two experimental groups (Fig.   5B ), there was a significant increase in the overall blood vessel area-to-islet area ratios (Fig. 5C ), attributed to increased average islet capillary size (Fig. 5D ) and intra-islet capillary diameter (Fig. 5E ), in c-KitβTg-HFD islets. Increased islet EC proliferation was ~2.3-fold higher than that of WT-HFD (3±1% vs. 1.3±0.2%; Fig. 5F ). The vasculature within pancreatic exocrine tissue remained unchanged between groups ( Fig. 5G and H) .
Although there were no significant differences in body, pancreas, or fat pad weights between cKitβTg-HFD and WT-HFD littermates ( Supplementary Fig. 4A-C) . Surprisingly overnight fasting blood glucose was significantly higher in c-KitβTg-HFD mice (Fig. 6A) . Glucose tolerance in c-KitβTg-HFD mice was progressively impaired, and there were significant increases in AUC when
IPGTT was performed after 20-22 weeks of HFD feeding ( Fig. 6B and C) . No significant changes in insulin tolerance were observed between groups ( Supplementary Fig. 4D ). In vivo GSIS assays showed significantly decreased plasma insulin levels at 35 minutes following glucose stimulation in c-KitβTg-HFD (Fig. 6D) . Impaired glucose tolerance of c-KitβTg-HFD mice was associated with significantly low number of islets (Fig. 6E) . Although average islet size was slightly increased (Fig 6F) , average β-cell size was comparable while total β-cell mass was significantly decreased in HFD-fed c-KitβTg mice ( Fig. 6G and H) . No significant changes were observed in β-cell proliferation between the experimental groups ( Fig. 6I) . Notably, total E-cadherin protein levels in the islets ( Higher levels of VEGF-A mRNA and protein were detected in c-KitβTg-HFD islets ( Fig. 7A and B), while cleaved PARP protein levels were increased ~45% (Fig. 7C ) with a significant increase in the number of TUNEL + β-cells (Fig. 7D) . Increased expression of Toll-like receptor 2 (TLR2) and inflammatory cytokine genes were further corroborated by western blot analyses showing that protein levels of TNF-α, IL-1β, and Mac-2 were elevated in c-KitβTg-HFD islets ( Fig. 7E and F) . Increased macrophage infiltration in the islets was determined by Mac-2 immunohistochemistry (Fig. 7G) ,
showing increased inflammatory responses in c-KitβTg-HFD islets. In contrast, those inflammatory cytokine genes were barely detectable and few macrophage deposits were observed in islets of mice fed a normal chow ( Supplementary Fig. 5A ), with no difference in Mac-2 protein levels between aged groups under normal diet feeding ( Supplementary Fig. 5B ).
Discussion
The present study demonstrates that endocrine pancreatic c-Kit signaling is a critical regulator of islet vascular formation (Fig. 8A) . to cytokine accumulation and macrophage deposition within islets of obesity-associated diabetic mice (20, 21, 34, 37, 38) . More importantly, our findings demonstrated that the over-stimulatory effect of c-Kit signaling on islet hyper-vasculature augments the inflammatory cycle and exacerbates β-cell death and dysfunction under chronic HFD condition (Fig. 8B) .
Notably, the observed glucose intolerance was associated with reduced in vivo insulin release, which was related to the loss of the cell-cell adhesion molecule E-cadherin on β-cells. E-cadherin is important for cell adhesion, forming adherens junctions that bind endocrine cells within islet clusters.
Recent studies indicated that treatment of β-cells with an anti-E-cadherin blocking antibody affected intracellular Ca 2+ levels and insulin secretion (39) . Furthermore, down-regulation of E-cadherin in β-cells can induce secretory defect and glucose intolerance (40) (41) (42) . The inter-relationship between E-cadherin and inflammatory cytokines has also been documented, where INFγ-treated human colonderived T84 epithelial cells led to a loss of membranous E-cadherin (43), and membrane-bound Ecadherin of prostatic cancer cells was disrupted during acute TNFα exposure (44) . These findings suggest that inflammatory cytokines influence membrane-localized E-cadherin, resulting in a loss of contact between cells and subsequent β-cell dysfunction in a long-term HFD setting.
In summary, our cell culture studies demonstrated that c-Kit regulation of VEGF-A production in β-cells via the Akt/mTOR/NFκBp65/HIF-1α pathway influences islet vasculature. Moreover, we
found that β-cell-specific c-Kit overexpression in vivo promoted islet vasculature in aged c-KitβTg + cells in the islets. Quantitative analyses of islet capillary density (Β), ratio of islet capillary area to islet area (C), average islet capillary size (D), and average islet capillary diameter (E) in pancreatic sections from all experimental groups. Western blot analyses of phospho-Akt (P-Akt) and total Akt (T-Akt), phospho-P70S6K (P-P70S6K) and total P70S6K (T-P70S6K), phospho-NFκBp65 (P-NFκBp65) and total NFκBp65 (TNFκBp65) (F), and VEGF-A and Pdx-1 protein expression (G) in islets isolated from 8-week-old male WT, c-Kit Under long-term HFD conditions, islets become hyper-vascularized, with increased cytokine production, macrophage infiltration, β-cell dysfunction and apoptosis.
